Correlation between Multidrug Resistance Infection with Clinical Outcomes of Critically ill Patients with COVID-19 Admitted to an Intensive Care at RSUP Dr. M. Djamil in Indonesia

Dedy Kurnia

doi:10.3889/oamjms.2022.9105

Authors

Dedy Kurnia Department of Anesthesiology and Intensive Care, Faculty of Medicine, Andalas University, M. Djamil Hospital, Padang, Indonesia https://orcid.org/0000-0002-0506-9803

DOI:

https://doi.org/10.3889/oamjms.2022.9105

Keywords:

COVID-19 severe, Intensive care unit, Multidrug resistance, Outcome

Abstract

BACKGROUND: Approximately 14–50% of severe COVID-19 patients are admitted to the Intensive Care Unit (ICU) that acquires a multidrug-resistant bacterial infection (MDR) and worsens clinical outcomes of patients.

AIM: We aim to determine the increased risk of MDR infection in the ICU including large-spectrum antibiotic administration, invasive procedure performance (mechanical ventilation), and clinical outcomes of patient.

METHODS: We analyzed 227 patients with a primary diagnosis of COVID-19 on mechanical ventilation who were admitted to ICU COVID-19 RSUP Dr. M. Djamil from 2020 to 2021. Demographic information, sputum culture results, intubation, and clinical outcomes were all collected in the medical records for this retrospective cohort study. Patients who were hospitalized for <48 h in the ICU were excluded from the study. An independent t-test and a Chi-square test were used to analyze the data.

RESULTS: In sixty patients (26.4%), bacteria were found in the sputum culture, 40 patients (66.7%) of them were MDR. The most common bacteria found was Acinetobacter baumanii (35%) followed by Klebsiella pneumonia (21.7%). There is a significant relationship between MDR (p-value 0.000) and intubation (p-value, 000) to clinical outcomes of patients (improvement or death). There is a significant relationship between intubation and MDR (p-value 0.009).

CONCLUSION: MDR patient status affected the outcomes of COVID-19 patients in the ICU. Patients with MDR were more likely to have a poor clinical outcome.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

World Health Organization. Organization World Health. Geneva: World Health Organization; 2021. https://doi.org/10.26719/2015.21.6.379 DOI: https://doi.org/10.26719/2015.21.6.379

Ramadan HKA, Mahmoud MA, Zakaria M, Aburahma, Elkhawaga AA, El-Mokhtar MA, et al. Predictors of severity and co-infection resistance profile in COVID-19 patients: First report from upper Egypt. Infect Drug Resist. 2020;13:3409-22. https://doi.org/10.2147/idr.s272605 PMid:33116660 DOI: https://doi.org/10.2147/IDR.S272605

Sharifipour E, Shams S, Esmkhani M, Khodadadi J, Fotouhi- Ardakani R. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis. 2020;20(1):646. https://doi.org/10.1186/s12879-020-05374-z PMid:32873235 DOI: https://doi.org/10.1186/s12879-020-05374-z

Soriano MC, Vaquero C, Ortiz-Fernández A, Caballero A, Blandino-Ortiz A, de Pablo R. Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19. J Infect. 2020;82:e20-1. https://doi.org/10.1016/j.jinf.2020.09.010 PMid:32956729 DOI: https://doi.org/10.1016/j.jinf.2020.09.010

Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: A systematic review and. J Infect. 2020;81(2):266-75. https://doi.org/10.1016/j.jinf.2020.05.046 PMid:32473235 DOI: https://doi.org/10.1016/j.jinf.2020.05.046

Baskaran V, Lawrence H, Lansbury L, Webb K, Zainuddin I, Huq T, et al. Co-infection in critically ill patients with COVID-19 : An observational cohort study from England. J Med Microbiol 2021;70(4):001350. https://doi.org/10.1101/2020.10.27.20219097 PMid:33861190 DOI: https://doi.org/10.1101/2020.10.27.20219097

Contou D, Claudinon A, Pajot O, Micaëlo M, Flandre PL, Dubert M, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intens Care. 2020;10(1):119. https://doi.org/10.1186/s13613-020-00736-x PMid:32894364 DOI: https://doi.org/10.1186/s13613-020-00736-x

Bogossian EG, Taccone FS, Izzi A, Yin N, Garufi A, Hublet S, et al. The acquisition of multidrug-resistant bacteria in patients admitted to COVID-19 intensive care units: A monocentric retrospective case control study. Microorganisms. 2020;8(11):1821. https://doi.org/10.3390/microorganisms8111821 PMid:33227956 DOI: https://doi.org/10.3390/microorganisms8111821

Pasero D, Cossu AP, Terragni P. Multi-drug resistance bacterial infections in critically ill patients admitted with COVID-19. Microorganisms. 2021;9(8):1773. https://doi.org/10.3390/microorganisms9081773 PMid:34442852 DOI: https://doi.org/10.3390/microorganisms9081773

Li J, Wang J, Yang Y, Cai P, Cao J, Cai X, et al. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: A retrospective analysis. Antimicrob Resist Infect Control. 2020;9(1):153. https://doi.org/10.1186/s13756-020-00819-1 DOI: https://doi.org/10.1186/s13756-020-00819-1

Palanisamy N, Vihari N, Meena DS, Kumar D, Midha N, Tak V, et al. Clinical profile of bloodstream infections in COVID- 19 patients: A retrospective cohort study. BMC Infect Dis. 2021;21(1):933. https://doi.org/10.1186/s12879-021-06647-x PMid:34496787 DOI: https://doi.org/10.1186/s12879-021-06647-x

Alfonso-Sanchez JL, Agurto-Ramirez A, Chong-Valbuena MA, De-Jesús-María I, Julián-Paches P, López-Cerrillo L, et al. The influence of infection and colonization on outcomes in inpatients with COVID-19: Are we forgetting something? Front Public Health. 2021;9:747791. https://doi.org/10.3389/fpubh.2021.747791 PMid:34869165 DOI: https://doi.org/10.3389/fpubh.2021.747791

Mędrzycka-Dąbrowska W, Lange S, Zorena K, Dąbrowski S, Ozga D, Tomaszek L. Carbapenem-Resistant Klebsiella pneumoniae Infections in ICU COVID-19 Patients a scoping review. J Clin Med. 2021;10(10):2067. https://doi.org/10.3390/jcm10102067 PMid:34066031 DOI: https://doi.org/10.3390/jcm10102067

Buehler PK, Zinkernagel AS, Hofmaenner DA, Garcia PD, Acevedo CT, Gómez-Mejia A, et al. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients. Cell Rep Med. 2021;2(4):100229. https://doi.org/10.1016/j.xcrm.2021.100229 PMid:33748789 DOI: https://doi.org/10.1016/j.xcrm.2021.100229